CCM
ALXN

Callodine Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Callodine Capital Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-77,500
Closed -$8.87M – 42
2020
Q3 		$8.87M Sell
77,500
-23,600
-23% -$2.7M 4.72% 7
2020
Q2 		$11.3M Buy
101,100
+38,600
+62% +$4.33M 5.56% 6
2020
Q1 		$5.61M Buy
62,500
+50,000
+400% +$4.49M 2.29% 15
2019
Q4 		$1.35M Buy
+12,500
New +$1.35M 0.54% 25